Bilihome aims to support jaundiced newborns and their parents, naturally. The wearable solution allows optimal blue light therapy and helps babies to recover in the right environment. By making the next steps towards a phototherapy wearable, we received the concept Red Dot: Best of the Best.
Wearable Phototherapy
60 percent of all newborns develop jaundice. 10 percent require therapy to avoid potential neurological damage. But common practice often requires hospitalization, leading to delayed discharge or readmission, mainly in the first week of life. During the treatment with blue light the baby is naked and blinded in a cot. A study conducted on "Maternal Experience with Neonatal Jaundice" described the experiences: